Cargando…

Serum CXCL9 as a potential marker of Type 1 inflammation in the context of eosinophilic asthma

Detalles Bibliográficos
Autores principales:	Hasegawa, Takehiro, Okazawa, Takahiro, Uga, Hitoshi, Kurata, Hirokazu, Mori, Akio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972734/ https://www.ncbi.nlm.nih.gov/pubmed/31125435 http://dx.doi.org/10.1111/all.13924

Ejemplares similares

Platelet Response to Allergens, CXCL10, and CXCL5 in the Context of Asthma
por: Gruba, Sarah, et al.
Publicado: (2022)

Development of a new HISCL automated CXCL9 immunoassay
por: Hasegawa, Takehiro, et al.
Publicado: (2023)

CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases–associated interstitial lung disease and interstitial pneumonia with autoimmune features
por: Kameda, Masami, et al.
Publicado: (2020)

Association of Eosinophilic Inflammation with FKBP51 Expression in Sputum Cells in Asthma
por: Tajiri, Tomoko, et al.
Publicado: (2013)

Eosinophilic Inflammation in Allergic Asthma
por: Possa, Samantha S., et al.
Publicado: (2013)

Development of eosinophilic pneumonia from eosinophilic bronchiolitis without asthma: A case report
por: Mikami, Erika, et al.
Publicado: (2023)

Suppressive effect of dexamethasone on murine Th9 cell-mediated nasal eosinophilic inflammation
por: Koyama, Teidai, et al.
Publicado: (2021)

Rapid and remarkable effectiveness of benralizumab for treating severe bronchial asthma with intractable eosinophilic rhinosinusitis and eosinophilic otitis media: A case report
por: Shimizu, Hideyasu, et al.
Publicado: (2020)

IL13 May Play an Important Role in Developing Eosinophilic Chronic Rhinosinusitis and Eosinophilic Otitis Media with Severe Asthma
por: Shimizu, Hideyasu, et al.
Publicado: (2021)

Periostin levels and eosinophilic inflammation in poorly-controlled asthma
por: Simpson, Jodie L., et al.
Publicado: (2016)

Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma
por: Kwon, Eun-Kyung, et al.
Publicado: (2021)

Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitis
por: Nukui, Yoshihisa, et al.
Publicado: (2019)

Value of peripheral blood eosinophil markers to predict severity of asthma
por: Casciano, Julian, et al.
Publicado: (2016)

Potential Masking of Airway Eosinophilic Inflammation by Combination Therapy in Asthma
por: Lee, Byung-Jae, et al.
Publicado: (2014)

Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma
por: Pelaia, Girolamo, et al.
Publicado: (2015)

Coexistence of diffuse panbronchiolitis and asthma: reciprocity of neutrophilic and eosinophilic inflammation
por: Takeyama, Kiyoshi, et al.
Publicado: (2017)

Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma
por: Vatrella, Alessandro, et al.
Publicado: (2022)

Bronchiectasis in severe asthma is associated with eosinophilic airway inflammation and activation
por: Frøssing, Laurits, et al.
Publicado: (2022)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation
por: Nuijsink, Marianne, et al.
Publicado: (2013)

IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
por: Maruoka, Hayato, et al.
Publicado: (2013)

Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis
por: Sampath, Pavithra, et al.
Publicado: (2023)

Severe Eosinophilic Asthma
por: Bakakos, Agamemnon, et al.
Publicado: (2019)

Eosinophils and childhood asthma
por: Choi, Bong Seok
Publicado: (2021)

Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma
por: Franceschi, Elisa, et al.
Publicado: (2022)

T-Helper Type 2 Cells Direct Antigen-Induced Eosinophilic Skin Inflammation in Mice
por: Kaminuma, Osamu, et al.
Publicado: (2018)

CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Sato, Tomoo, et al.
Publicado: (2013)

Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?
por: Van Hulst, Glenn, et al.
Publicado: (2021)

Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
por: Matsumoto, Ari, et al.
Publicado: (2023)

Eosinophil Development, Regulation of Eosinophil-Specific Genes, and Role of Eosinophils in the Pathogenesis of Asthma
por: Uhm, Tae Gi, et al.
Publicado: (2012)

Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan
por: Miyata, Yoshiharu, et al.
Publicado: (2023)

Peripheral blood Th9 cells and eosinophil apoptosis in allergic asthma patients
por: Hoppenot, Deimante, et al.
Publicado: (2014)

FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis
por: Mulder, D J, et al.
Publicado: (2009)

Angiotensin-(1–7) Promotes Resolution of Eosinophilic Inflammation in an Experimental Model of Asthma
por: Magalhaes, Giselle S., et al.
Publicado: (2018)

Platelet–Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma
por: Shah, Sajeel A., et al.
Publicado: (2017)

Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives
por: Nhu, Quan M., et al.
Publicado: (2017)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Tissue Inhibitor of Metalloproteinase-1 Enhances Eosinophilic Airway Inflammation in Severe Asthma
por: Cao, Thi Bich Tra, et al.
Publicado: (2023)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
por: Najmaddini, Hamid, et al.
Publicado: (2014)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p5c59lkoeguqec5cl382j0c995